Search the Community

Showing results for tags 'lungevity'.

More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


    • LUNG CANCER 101
    • HOPE
    • GRIEF


  • An Advocate's Perspective
  • Cheryncp123's Blog
  • Lung Cancer Stories
  • PeggieH
  • Stay The Course
  • Caregivers Connection
  • Spree
  • Volunteer Voices


There are no results to display.

Found 57 results

  1. I noticed something recently at the in-person support group I facilitate. Caregivers in my group didn't speak up about issues or feelings unless the facilitator or group leader mentioned them first. "Like Jan said, I have feelings of ____ too." After the third time, it occured to me that caregivers are either waiting to have their feelings validated by someone else or didn't realize they had been feeling those feelings. I remember being a caregiver for my father and how all-encompassing that was. Nothing else mattered to me at the time. Everything was about my dad's cancer, his feelings, his happiness, his peace and comfort. I don't think I got more than 2-3 hours of sleep a night during those 11 months- there was just so much to do! I completely lost myself and any sense of "me" during my caregiving. I would never consider taking time for myself, taking a break or openly expressing my frustrations and concerns- that would be selfish- afterall, I wasn't the one in treatment with cancer. I wasn't the one fighting for my life, right? If given the opportunity then, would I have taken advantage of caregiver resources or support groups? Would I even know what I was feeling or how to describe it? Until we are able to have caregiver-only support groups in every community, how can we give caregivers the encouragement or "permission" to put a voice to what they are feeling? How do we as caregivers divorce ourselves from the guilt that accompanies self-care? Thoughts?
  2. MONDAY, JUNE 5 Reuters “Roche's Alecensa bests Pfizer's Xalkori in lung cancer trial” Forbes “A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us” The Telegraph (UK) “Cancer Patients Who Enter Their Symptoms into an App Live Longer than Expected, Study Suggests” Patient Daily “FDA OKs Novartis’ Zykadia for Metastatic Lung Cancer Affecting the Brain” TUESDAY, JUNE 6 Drug Discovery & Development “ASCO 2017: Investigational Agent Improves Survival Outcomes for EGFR-Positive Lung Cancer” The Washington Post “8 Things Doctors are Buzzing about at the Biggest Cancer Meeting” WEDNESDAY, JUNE 7 Fannin Sentinel “Lungevity: Shining Light on the Invisible Disease” PR Newswire “Julie R. Brahmer, MD., MSc, is recognized by Continental Who's Who” Healio “Pembrolizumab Reduces Need for Second-Line Therapy in Advanced NSCLC”{7d9e7f9c-c66a-4f06-9ab3-e95da959cad5}/pembrolizumab-reduces-need-for-second-line-therapy-in-advanced-nsclc ASCO Daily News “Studies Explore Targeted Therapies in Lung Cancer” THURSDAY, JUNE 8 The New York Times “Cancer Drug Proves to Be Effective Against Multiple Tumors” The New York Times “When Your Personal War on Cancer Is Exhausting” EurekAlert “Scientific Advances in Thoracic Oncology in 2016 Highlighted by the IASLC” FRIDAY, JUNE 9 Healio “Primary NSCLC May Be Underdiagnosed Among Patients with Metastatic Renal Cell Carcinoma”{97a56d74-d2e8-44d3-942a-7e8f636341b7}/primary-nsclc-may-be-underdiagnosed-among-patients-with-metastatic-renal-cell-carcinoma Cure Today “Expert Discusses the Future of EGFR+ and ALK+ Lung Cancer” USA Today “’How Long Have I Got?’: Why Many Cancer Patients Don’t Have Answers ”
  3. Here is the weekly clip report: TUESDAY, MAY 30 Miami Herald “Using Your Immune System to Fight Cancer is Showing Significant Promise” Cancer Network “Certinib Gets First-Line FDA Approval ALK-Positive Lung Cancer” WEDNESDAY, MAY 31 CHEST (American College of Chest Physicians) “What You Need to Know About Biopsies for Lung Cancer” OncLive “Modern Biopsy Techniques Changing the Scope of Lung Cancer Diagnosis” Reuters “Cancer Meeting to Provide Clues on Future Immunotherapy Combos” Genome Web “Vanderbilt Team Using Mass Spec to Research Cancer Immunotherapy” THURSDAY, JUNE 1 Lung Cancer News Today “Trilaciclib Improves Chemo’s Effectiveness Against Small Cell Lung Cancer, Study Finds” PR Newswire “Roche Announces FDA Approval of Companion Diagnostic to Identify ALK-Positive Non-Small Cell Lung Cancer Patients” Business Wire “Atreca, Inc., and Dana-Farber Cancer Institute Establish Broad Cancer Immunotherapy R&D Collaboration” NBC News “More New Cancer Drugs Mean Higher Costs But Also Longer Lives” FRIDAY, JUNE 2 Bloomberg “A Hot-Cancer Drug Race Keeps Getting More Crowded” Business Insider “The FDA and a $1.2 Billion Startup Are Analyzing How Drugs Are Used After Approval – and It Could One Day Change How we Treat Cancer” U.S. News & World Report “As Scientists Train the Immune System to Fight Cancer, Others Look to Combat Costs”
  4. 50% of the proceeds from this soccer camp in Columbia, MD, will be donated to LUNGevity Foundation! Soccer Camp.pdf
  5. MONDAY, MAY 22 USA Today “Hope Summit is Just that for Lung Cancer Survivors” Patient Daily “AstraZeneca Reports Positive Results in Trial Using Imfinzi in Stage III Non-Small Cell Lung Cancer Cases” TUESDAY, MAY 23 Business Insider “The FDA just Took an Entirely New Approach Approving a Cancer Drug” Clinical Oncology News “ASCO Report: Gefitinib beats Chemo After Surgery in NSCLC” U.S. News & World Report “Advice for Lung Cancer Caregivers” WEDNESDAY, MAY 24 Medical Xpress “Using a Genetic Signature to Overcome Chemotherapy-Resistant Lung Cancer” Reuters “Brief – Onocyte Presents Positive Lung Cancer Blood Test Data at American Thoracic Society” THURSDAY, MAY 25 Genome Web “OncoCyte Lung Cancer Test Validation Data Bodes Well for Launch This Year” PR Newswire “NCCN Awards Grants to Investigators at Member Institutions to Study Osimertinib in Lung Cancer” FRIDAY, MAY 26 Cancer Therapy Advisor “Lung Cancer Radiotherapy Might Improve Immune Checkpoint Blockade-Associated Survival” Cure Today “FDA Approves Zykadia for Metastatic Non-Small Cell Lung Cancer” Patient Daily “Gefitinib Shown to Delay Recurrence of Lung Cancer Following Surgery” The ASCO Post “The Ongoing Challenges of Lung Cancer Screening” ASCO Daily News “Targeting RET Rearrangements in Non–Small Cell Lung Cancer”
  6. MONDAY, MAY 15 Medscape “What’s New for Lung Cancer? Stay Tuned for ASCO 2017” TUESDAY, MAY 16 Healio “Survivors of Hodgkin Lymphoma Have Increased Risk for Second Cancer”{099e0b29-8044-4d8c-8215-f0691027f7d8}/survivors-of-hodgkin-lymphoma--increased-risk-for-second-cancer Forbes “How AI and Deep Learning is now Used to Diagnose Cancer” WEDNESDAY, MAY 17 Medical Xpress “Brigatinib First to Offer Over 1-Year Control of ALK-Positive Lung Cancer Post-Crizotinib” U.S. News & World Report “Cancer Fatigue: So Tired by Treatment” Boston Globe “Two MGH Doctors Offer Step-by-Step Advice for Living with Cancer” THURSDAY, MAY 18 Reuters “Merck, Incyte Immunotherapy Combination Effective in Lung Cancer Study” Medical Xpress “Targeted Therapy Can Delay Recurrence of Intermediate-Stage Lung Cancer” FRIDAY, MAY 19 Reuters “CHMP Backs Novartis's Zykadia for First-Line Use in Lung Cancer” News-Medical “Researchers Discover Novel Mechanism That Causes Malignant Pleural Effusion in Lung Cancer Patients”
  7. Last week, the FDA approved the first immunotherapy combination – using immunotherapy with chemotherapy. Now, Opdivo*, in combination with ALIMTA* and carboplatin, may be recommended for patients with metastatic non-squamous non-small cell lung cancer in the first-line setting. This combination is only approved for patients who do not have a molecular target, such as EGFR, ALK, or ROS1. The approval has generated a lot of questions in the survivor community. Do you have questions? post them below. Register now to join us TOMORROW. It's going to be a great live conversation.
  8. Here is the weekly clip report: MONDAY, MAY 8 Medical Xpress “Study Identifies New Target to Fight Prostate, Lung Cancer” WTIU-FM (Indiana Public Media) “New Study To Examine Why Patients Choose Lung Cancer Screenings” Cancer Network “Checkpoint Inhibitors Improve Response to Salvage Chemotherapy in NSCLC” TUESDAY, MAY 9 US News & World Report “Here’s How to Manage Lung Cancer Side Effects” New York Post “How Assembling the Right Cancer Team May Save Your Life” WEDNESDAY, MAY 10 WETA-TV (PBS—Washington, DC) “This Cuban Lung Cancer Drug Is Giving Some U.S. Patients Hope” Cure “Will Immunotherapy Move into All Lung Cancer Patient Populations?” THURSDAY, MAY 11 Lung Cancer News Today “Clinical Trial to Test Biocept’s Target Selector Platform as Diagnosis, Monitoring Tool for Lung Cancer” Reuters “U.S. FDA Approves Merck Immunotherapy/Chemo Combo for Lung Cancer” FRIDAY, MAY 12 Fortune “Why Merck’s Keytruda Just Became a Lung Cancer Game Changer” Cancer Therapy Advisor “Alectinib Beats Crizotinib in ALK-positive Non-small Cell Lung Cancer” Eurek Alert “Invasive Lung Cancer Cells Display Symbiosis -- Key to metastasis” Reuters “AstraZeneca’s Durvalumab Shown in Trial to Reduce Risk of Death from Lung Cancer”
  9. Advocates are courageous and brave as they raise awareness or work tirelessly to change injustices and create a better world. Most people become advocates because they were personally affected by the cause they are fighting for. While they have smiles on their faces and work to inspire...there's a part of their hearts that are always grieving for the love they lost or the life that once was. At least thats true for me- even after 15 years. While our personal experience fuels us during advocacy events and awareness days we are also acutely aware of the absence of those who were lost to the disease and reminded that a part of our life is forever changed. Advocacy is a way to turn a terrible life experience into education, awareness, and support for soneone facing similar challenges. Advocacy events and activities can be personally rewarding and advocacy efforts can assist others and even change their lives. Being an advocate is amazing and meaningful. While I celebrate the progress I've been a part of and the lives I've helped to change, a part of me is alwaying grieving a little bit. I've learned that grief is most definitely one emotion that fuels advocacy. As long as I advocate for people with lung cancer, I will never stop grieving for my dad. Everything I advocate for reminds me that he's no longer here. Part of me finds comfort that he is still "with" me after all these years while other relatives have long stopped saying his name. While I'm on a mission to provide all these things to improve a patients survivorship, I'm reminded that my dad never had these things and he did not have a fair shot at survival. It's really bittersweet. Even though there is a an undercurrent of sadness-- turning tragedy into purpose and a mission honors my dad. Its also the most rewarding feeling to serve others and help to change their lives
  10. Lung Cancer Navigator App Aims to Help Patients Understand Disease Oncology Nurse Advisor: LUNGevity, a lung cancer-focused nonprofit organization, has launched a new mobile application designed to help patients with lung cancer better understand their disease and make living with lung cancer less daunting.1 The mobile app, called Lung Cancer Navigator, is a customizable app that provides the latest medical and treatment information related to patients' specific lung cancer diagnosis. In addition, it offers tools for organizing customized care, managing multiple medications, and describing and tracking symptoms. Patients may use the app to input reminders and keep a list of questions for their next doctor visit.
  11. When diagnosed with lung cancer, there are often more questions than answers. How do you get information you need to make the best decisions about your care? When exactly does survivorship begin? Katie Brown, Vice President of Support and Survivorship Programs at LUNGevity Foundation, shares her personal connection to lung cancer and why she is so passionate about helping patients find the best resources at the time they need them the most.
  12. Here is the weekly clip report: TUESDAY, MAY 2 US News “The Link Between Air Pollution and Lung Cancer” Cure “Adding Mindfulness: Innovation for an Optimal Preoperative Rehabilitation Before Lung Cancer Resection” WEDNESDAY, MAY 3 Cure “Speaking the Language of Lung Cancer” NPR “Urgent Care Services for Cancer Patients Offer a Gentler ER Alternative” Medscape “The Evolving Landscape for EGFR Mutation-Positive Advanced NSCLC: Clarifying a New Standard of Care” Fortune Magazine “This Is What’s Missing in the Data-Centric Approach to Cancer” Forbes “Joe Biden on His New Cancer Initiative, Drug Prices and Donald Trump” THURSDAY, MAY 4 Vanderbilt News “Lovly Elected to American Society for Clinical Investigation” Targeted Oncology “Expert Highlights Benefits of Next-Generation Sequencing for NSCLC” FRIDAY, MAY 5 Huffington Post “Using AI to Spot Lung Cancer” The Science Times “Air Pollution Induces Lung Cancer Too: Here’s What You Should Know”
  13. MONDAY, APRIL 17 Onc Live “Immunotherapy Agents, Combinations to Compete for Frontline NSCLC” Reuters “OncoMed's lung cancer drug fails mid-stage study, shares tumble” Cure Today “All in the Family: Discussing Screenings and Preventative Surgery for Inherited Cancers” TUESDAY, APRIL 18 Chicago Tribune “Breathe Deep North Shore Aimes to Focus Attention on Lung Cancer” US News – Health “New Treatments for Lung Cancer” Lung Cancer News Today “Opdivo More Than Tripled 5-Year Survival Rates in NSCLC Patients in Phase 1 Study” WEDNESDAY, APRIL 19 Media News Today “Lung Cancer: Blood Test May Lead to Earlier, Personalized Treatment” The Huffington Post “’State of the Air 2017’ – Who’s Best and Worst?” THURSDAY, APRIL 20 Medical Xpress “New Test for Early Detection of Lung Cancer Measures Tiny Charges in the Composition of Breath” FRIDAY, APRIL 21 Cancer Therapy Advisor “In Focus: Atezolizumab for Non-small Cell Lung Cancer”
  14. MONDAY, APRIL 10 Fox Sports “This Week’s Bow Tie Represents … LUNGevity” The Huffington Post “Getting Screened: Taking Charge Of Your Own Health May Save Your Life” TUESDAY, APRIL 11 Lohud (USA Today) “Pulmonary Rehabilitation Proves Effective for Some Lung Cancer Patients” Lung Cancer News Today “Genentech’s Alecensa Superior to Xalkori in Newly Diagnosed ALK+ Advanced NSCLC Patients” WEDNESDAY, APRIL 12 PR Newswire “Alice Shaw of Massachusetts General Hospital and Harvard University Joins the LUNGevity Foundation Scientific Advisory Board” Forbes “Which Cancer Patients Will be Helped by Powerful Immune Drugs” THURSDAY, APRIL 13 Onc Live “Liquid Biopsy Testing Detects Recurrence in High-Risk NSCLC” FRIDAY, APRIL 14 Washington Life Magazine “LUNGevity Musical Celebration of Hope Gala”
  15. LUNGevity Foundation, the nation’s preeminent lung cancer research foundation, today announced that Alice T. Shaw, MD, PhD, has joined LUNGevity’s Scientific Advisory Board, a group of 20 world-renowned scientists and researchers that guides LUNGevity’s research program. The Scientific Advisory Board is integral to the Foundation, overseeing the scientific strategy and ensuring that grants are awarded to the researchers whose proposals demonstrate the greatest potential for finding lung cancer at its earliest, most treatable phase, as well as extending and improving lives of lung cancer survivors. LUNGevity is the only lung cancer organization with a programmatic focus on early detection and Career Development Awards. Our researchers are working on finding a better way to detect lung cancer, and to better diagnose, treat, and prevent its recurrence. The research program is a crucial factor in moving the science forward to improve outcomes for people living with lung cancer. Dr. Shaw is the Director of the Center for Thoracic Cancers and the Paula O’Keeffe Endowed Chair of Thoracic Oncology at Massachusetts General Hospital. She is also an Associate Professor of Medicine at Harvard Medical School. In addition to caring for patients with lung cancer, Dr. Shaw performs clinical and translational research. Her clinical research focuses on subsets of NSCLC that have unique driver mutations, such as EGFR, ALK, and ROS1. Her translational research focuses on understanding and making clear the mechanisms of resistance to targeted therapies; she is currently developing novel combination treatment strategies. Her research has helped to develop numerous FDA-approved targeted therapies for patients with oncogene-driven NSCLC, such as crizotinib (Xalkori®) for patients with ALK or ROS1 rearrangements. “We could not be happier that Dr. Shaw has joined our Scientific Advisory Board,” said Andrea Ferris, President and Chairman of LUNGevity Foundation. “She is a brilliant thinker, an innovator, and a compassionate advocate for her patients. In particular, her groundbreaking work that led to the development of Xalkori® has extended and improved the lives of many NSCLC patients. Her expertise and counsel will advance LUNGevity’s goal to increase and improve survivorship for those affected by lung cancer.” Read the full press release here.
  16. Here is the weekly clip report: MONDAY, APRIL 3 PR Newswire “LUNGevity Launches Groundbreaking Platform for Patient Voices” ABC News “U.S. Cancer Deaths are Decreasing, Study Finds” The Blade “UT Researchers Map Genetic Code to Determine Cancer Risk” TUESDAY, APRIL 4 WWTV-TV (CBS—Traverse City, MI) “LUNGevity Launches Groundbreaking Platform for Patient Voices” Lung Cancer News Today “Screening Initiative in Georgia Finds Twice the Lung Cancer Rate of Previous Efforts” WEDNESDAY, APRIL 5 OncLive “Frontline Setting for ALK+ NSCLC Set to Undergo Shift” Oncology Nursing News “Nivolumab 5-Year Survival Rate Exceeds Expectations in NSCLC” THURSDAY, APRIL 6 CNBC “The Land of Vikings May Hold the Cure for Cancer” MIT News “Study Helps Explain Varying Outcomes for Cancer, Down Syndrome” Lung Cancer News Today “Alecensa Improves Progression-Free Survival in Certain Lung Cancer Patients” FRIDAY, APRIL 7 “When Health Advocates Can’t Save Themselves”
  17. We have several possible media opportunities for individuals who are using the Lung Cancer Navigator App to help manage their/their loved one's lung cancer diagnosis. If you are interested in sharing your story and helping to raise awareness for this resource, please respond to this thread and we will be in touch with more information. If you would like to learn more about the Lung Cancer Navigator App and how to download it for free from the Apple or Google Play stores, please visit LUNGevity's website. Thank you! Lauren -- Digital Community Manager LUNGevity Foundation
  18. LUNGevity Foundation has launched Patient FoRCe, the first-ever critical bridge to connect the voices of lung cancer patients — a significant population — with health care professionals, regulators, policymakers, and developers of drugs. “Lung cancer is the #1 cancer killer, taking the lives of 157,000 Americans every year. LUNGevity is leading the way in changing the paradigm of cancer treatment ─ from assuming patient wishes to evidence-based conclusions about what patients value,” said LUNGevity Chairman Andrea Stern Ferris. “Through Patient FoRCe, lung cancer patient voices will be heard and heeded as policy is developed, research is conducted, and treatment decisions are made.” Patient FoRCe, LUNGevity’s Patient-Focused Research Center, will undertake never-before studies of those living with lung cancer, collecting and sharing robust qualitative and quantitative data about lung cancer patients’ preferences and experiences to inform treatment, as well as relevant policy and research protocols. Patient FoRCe’s immediate focus will include continuing a study of patient preferences and experiences regarding access to care, treatment and diagnostic options, and the impact of symptoms on daily living, as well as conducting studies to facilitate patients’ access to biomarker testing, which is essential to implementing precision medicine. Patient FoRCe will also initiate a study into increasing adherence to lung cancer screening protocols for people at high risk for lung cancer. Additional projects will be based on stakeholder input and the guidance of an external advisory board of survivors, academic and community clinicians, industry partners, patient advocacy groups, and community partners. LUNGevity formally announced Patient FoRCe at the American Association for Cancer Research’s 2017 Annual Meeting in Washington, DC, on Sunday, April 2. Andrea Stern Ferris spoke to the urgency of the initiative, saying, “For too long, public policy, the practice of medicine, and drug development have not adequately integrated the viewpoint of patients. LUNGevity is determined to change that paradigm. By incorporating the patient’s voice into every step of the process – in policymaking, in trials, in treatments – we will improve outcomes for those diagnosed with lung cancer.” “Our goal is to uncover gaps in information, misperceptions about patient attitudes, and areas of unmet patient need,” explained Dr. Upal Basu Roy, Director of Patient FoRCe. “LUNGevity is the only organization driving this type of change for the lung cancer community, and we anticipate that our findings will shape the future of lung cancer care.” For more information about Patient FoRCe, visit Click here to read the full press release.
  19. Good evening, LCSC! Here is the weekly clip report: MONDAY, MARCH 27 OncLive “Expert Provides Perspective on Immunotherapy Advances in Lung Cancer” R&D Magazine “Cancer Linked to DNA Copying Mistakes” United Press International “New Color Change Test May Advance Cancer Research” TUESDAY, MARCH 28 Oncology Nurse Advisor “Free Lung Cancer Screening Findings Support Continual Screenings in High-Risk Populations” OncLive “Efforts Continue to Introduce Immunotherapy into Earlier NSCLC Settings” BioAnalysis Zone “Lung Cancer Recurrence Detected Earlier Circulating Tumor Cell Test” WEDNESDAY, MARCH 29 All Events “Join Team LUNGevity for the Bank of America Chicago Marathon” Oncology Nurse Advisor “CTCs Promising as Biomarker to Identify Lung Cancer Recurrence” THURSDAY, MARCH 30 Medical Xpress “Studies Find Promise for Innovations in Liquid Biopsies” “How AbbVie is Attacking Tumors at their Roots” FRIDAY, MARCH 31 Cure Today “Tagrisso gets Full Approval in Lung Cancer” Healio “Annual report: Overall cancer death rates continue to decline, but problem areas persist”{01baf9ad-ff7a-4166-afd5-ceeaf73717ba}/annual-report-overall-cancer-death-rates-continue-to-decline-but-problem-areas-persist
  20. Good evening! Here is the weekly clip report: MONDAY, MARCH 6 Reuters “OncoCyte says study confirms accuracy of lung cancer blood test” Oncology Live “Ongoing Research of Immunotherapy in HNSCC” TUESDAY, MARCH 7 Oncology Live “Dr. Levine on Palliative Care for NSCLC” PR Newswire “Trovera™ EGFR Urine Liquid Biopsy Test Predictive of Clinical Response to Therapy: Case Series in Patients with Non-Small Cell Lung Cancer” WEDNESDAY, MARCH 8 Technology Networks “Towards Noninvasive Detection of Lung Cancer” CURE: Cancer Updates, Research & Education “SBRT Is Promising in Early-Stage Lung Cancer, Though Not Widely Used” THURSDAY, MARCH 9 Lung Cancer News Today “New Pathway Controlling Spread of Lung Cancer Could Be Targeted for Therapy” Bel Marra Health “Nasal swab may be useful for confirming lung cancer diagnosis” FRIDAY, MARCH 10 Drug Discovery & Development “OncoCyte Reports Successful Results of Lung Cancer Diagnostic Test Study” Medical Xpress “Cancer immunotherapy: Revived T cells still need fuel” WKBT-TV (CBS – La Crosse, WI) “Lung cancer screenings can save lives”
  21. Here is the weekly clip report: MONDAY, MARCH 13 CBS News “On The Horizon: the cancer breath test” Tulane University “Tulane researcher shows more education eases cancer patients’ fear"’-fear TUESDAY, MARCH 14 Cure “What’s Next for Immunotheraoy and Targeted in Lung Cancer?” Clinical Leader “Heat Biologics Meets Efficacy Endpoint in its Phase 1b Lung Cancer Trial to Progress to Phase 2” WEDNESDAY, MARCH 15 Triage Cancer “Triage Cancer Conferences” The Scientist “Antibody Therapy Targets Cancer Stem Cells: Study” Immuno-Oncology News “T-cells Need Extra Boost After Activation by Immune Checkpoint Inhibitors, Study Shows” THURSDAY, MARCH 16 U.S. News & World Report “Cancer and Infertility: Why Aren’t More Women Being Told About the Risks?” Medical Xpress “Prevention and prediction: Understanding how lung cancer progresses” FRIDAY, MARCH 17 “Altuve Meet and Greet Part of Charity Auction” News-medical “Penn studies provide new understanding of lung cancer progression and prevention” Healio “Multiple Biopsies May Help Identify, Treat Resistance in NSCLC”{ea75e3de-cbe0-4052-a0aa-86ca1516b426}/multiple-biopsies-may-help-identify-treat-resistance-in-nsclc
  22. Here is the weekly clip report: MONDAY, FEBRUARY 27 The Baltimore Sun “Buck Showalter ensuring Orioles keep memory of former PR director Monica Barlow” Medical News Today “Nasal swab could help diagnose lung cancer” TUESDAY, FEBRUARY 28 Bloomberg “Coffee Shop Meeting Inspires Novel Way to Kill Cancer” Yale Daily News “Yale study examines lung cancer metastasis” WEDNESDAY, MARCH 1 Yahoo “Latest Health Union Survey Finds Lung Cancer Patients Stressed and Scared but Hopeful” Oncology Live “Toxicities Associated with Anti-PD-1 Immunotherapy" THURSDAY, MARCH 2 Lung Cancer News Today “New Pathway Controlling Spread of Lung Cancer Could Be Targeted for Therapy” Bel Marra Health “Nasal swab may be useful for confirming lung cancer diagnosis” FRIDAY, MARCH 3 PR Web “The ‘Informed’ Series, Hosted by Rob Lowe, Will Cover Lung Cancer Treatment in a New Segment” Medical News Today “Cancer-related fatigue: Exercise, psychological therapies best treatments”
  23. We all know that when someone receives a lung cancer diagnosis, it can be overwhelming. LUNGevity designed the Lung Cancer Navigator app is to empower patients and make understanding and living with lung cancer less daunting and considerably more manageable. The Lung Cancer Navigator mobile app puts your entire support network in the palm of your hand. It helps you understand your diagnosis and provides tools and forums for asking questions, detailing symptoms, and managing medications. The app is a great way to communicate with your healthcare providers and to request support from friends and family. Follow these easy steps to get started! WATCH the introductory video for a quick demonstration of how the Lung Cancer Navigator works. DOWNLOAD the free LUNGevity Lung Cancer Navigator from Google Play or the Apple App Store. VIEW these step-by-step instructions to set up your app. TELL US what you think! We’re eager to know what you find most beneficial and how we can make the Lung Cancer Navigator even more helpful in the future.
  24. MONDAY, FEBRUARY 20 CURE: Cancer Updates, Research & Education “Mobile App Helps Patients Navigate a Lung Cancer Diagnosis at the Touch of a Button” Medical Xpress “Discovery of a new gene critical in the development of lung and pancreatic cancers” TUESDAY, FEBRUARY 21 Oncology Live “Molecular Testing for NSCLC in 2017” CURE: Cancer Updates, Research & Education “Agent Shows Promise and Safety in Small Cell Lung Cancer” WEDNESDAY, FEBRUARY 22 “FDA grants priority review to Zykadia for ALK–positive metastatic NSCLC”{d9871c02-8446-4d05-8750-c542fc10cd7f}/fda-grants-priority-review-to-zykadia-for-alk-positive-metastatic-nsclc The Hill “Cancer treatment is changing and coverage must change with it” THURSDAY, FEBRUARY 23 Oncology Live “Clinical Trial Reform is Urgently Needed” Medical Xpress “Digital pathology platforms can now determine the metastatic potential of cells in a tissue biopsy” FRIDAY, FEBRUARY 24 NPR “Advice From Patients On A Study's Design Makes For Better Science” Weill Cornell Medicine Newsroom “New Type of Genetic Mutation Identified in Cancer”
  25. Good evening! Here is the weekly clip report: MONDAY, FEBRUARY 13 It’s Your Health “Linda Wenger of Lungevity” Advantage News “Health center offers new lung cancer screening tool” Oncology Live “Rovalpituzumab Tesirine Active and Safe in Small Cell Lung Cancer” TUESDAY, FEBRUARY 14 Lung Cancer News Today “Study of Aggressive Lung Cancer Subtype May Pave Way for Targeted Treatment” Med City News “Penn Medicine wields Big Data to help lung cancer patients avoid ER” Bio Pharma Dive “Liquid Biopsies: The Next Frontier in Cancer?” WEDNESDAY, FEBRUARY 15 Yale News “Limiting lung cancer’s spread and growth in the brain” CancerNetwork “Understanding the Links Between Lung Cancer, COPD, and Emphysema: A Key to More Effective Treatment and Screening” THURSDAY, FEBRUARY 16 KFM Radio (San Diego, CA) “Acclaimed Country Artist Wade Hayes to Perform and Share His Cancer Story at LUNGevity HOPE Summit” CURE: Cancer Updates, Research & Education “Another Year of Lung Cancer Advancements Expected in 2017” FRIDAY, FEBRUARY 17 SELF “The One Very Subtle Symptom of Lung Cancer You Need to Know” CURE: Cancer Updates, Research & Education “Agent Shows Promise and Safety in Small Cell Lung Cancer”